Powers JF - Search Results

1

Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.

Sladek NE, Doeden D, Powers JF, Krivit W. Sladek NE, et al. Among authors: powers jf. Cancer Treat Rep. 1984 Oct;68(10):1247-54. Cancer Treat Rep. 1984. PMID: 6395951

2

Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.

Powers JF, Sladek NE. Powers JF, et al. Cancer Res. 1983 Mar;43(3):1101-6. Cancer Res. 1983. PMID: 6825082 No abstract available.

3

Half-life of oxazaphosphorines in biological fluids.

Sladek NE, Powers JF, Grage GM. Sladek NE, et al. Among authors: powers jf. Drug Metab Dispos. 1984 Sep-Oct;12(5):553-9. Drug Metab Dispos. 1984. PMID: 6149904

4

Influence of diuretics on urinary general base catalytic activity and cyclophosphamide-induced bladder toxicity.

Sladek NE, Smith PC, Bratt PM, Low JE, Powers JF, Borch RF, Coveney JR. Sladek NE, et al. Among authors: powers jf. Cancer Treat Rep. 1982 Nov;66(11):1889-1900. Cancer Treat Rep. 1982. PMID: 7139634

5

A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+/- rats.

Powers JF, Cochran B, Baleja JD, Sikes HD, Pattison AD, Zhang X, Lomakin I, Shepard-Barry A, Pacak K, Moon SJ, Langford TF, Stein KT, Tothill RW, Ouyang Y, Tischler AS. Powers JF, et al. Endocr Relat Cancer. 2020 Oct;27(10):X9-X10. doi: 10.1530/ERC-19-0474e. Endocr Relat Cancer. 2020. PMID: 32861212 Free PMC article. No abstract available.

6

Targeting pheochromocytoma/paraganglioma with polyamine inhibitors.

Rai SK, Bril F, Hatch HM, Xu Y, Shelton L, Kalavalapalli S, Click A, Lee D, Beecher C, Kirby A, Kong K, Trevino J, Jha A, Jatav S, Kriti K, Luthra S, Garrett TJ, Guingab-Cagmat J, Plant D, Bose P, Cusi K, Hromas RA, Tischler AS, Powers JF, Gupta P, Bibb J, Beuschlein F, Robledo M, Calsina B, Timmers H, Taieb D, Kroiss M, Richter S, Langton K, Eisenhofer G, Bergeron R Jr, Pacak K, Tevosian SG, Ghayee HK. Rai SK, et al. Among authors: powers jf. Metabolism. 2020 Sep;110:154297. doi: 10.1016/j.metabol.2020.154297. Epub 2020 Jun 18. Metabolism. 2020. PMID: 32562798 Free PMC article.

7

Immunohistochemical Staining for SOX10 and SDHB in SDH-Deficient Paragangliomas Indicates that Sustentacular Cells Are Not Neoplastic.

Powers JF, Tischler AS. Powers JF, et al. Endocr Pathol. 2020 Sep;31(3):307-309. doi: 10.1007/s12022-020-09633-2. Endocr Pathol. 2020. PMID: 32562155 No abstract available.

8

A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+/- rats.

Powers JF, Cochran B, Baleja JD, Sikes HD, Pattison AD, Zhang X, Lomakin I, Shepard-Barry A, Pacak K, Moon SJ, Langford TF, Stein KT, Tothill RW, Ouyang Y, Tischler AS. Powers JF, et al. Endocr Relat Cancer. 2020 Jun;27(6):337-354. doi: 10.1530/ERC-19-0474. Endocr Relat Cancer. 2020. PMID: 32252027 Free PMC article.

9

A Previously Unrecognized Monocytic Component of Pheochromocytoma and Paraganglioma.

Farhat NA, Powers JF, Shepard-Barry A, Dahia P, Pacak K, Tischler AS. Farhat NA, et al. Among authors: powers jf. Endocr Pathol. 2019 Jun;30(2):90-95. doi: 10.1007/s12022-019-9575-6. Endocr Pathol. 2019. PMID: 31001800 Free PMC article.

10

A unique model for SDH-deficient GIST: an endocrine-related cancer.

Powers JF, Cochran B, Baleja JD, Sikes HD, Zhang X, Lomakin I, Langford T, Stein KT, Tischler AS. Powers JF, et al. Endocr Relat Cancer. 2018 Nov;25(11):943-954. doi: 10.1530/ERC-18-0115. Epub 2018 Jul 2. Endocr Relat Cancer. 2018. PMID: 29967109 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page